Get the Stockscreener App
38.50
1.96%
-0.77
Bruker Corp stock is traded at $38.50, with a volume of 1.44M.
It is down -1.96% in the last 24 hours and down -9.54% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$39.27
Open:
$39.56
24h Volume:
1.44M
Relative Volume:
0.63
Market Cap:
$5.85B
Revenue:
$3.44B
Net Income/Loss:
$-8.30M
P/E Ratio:
-258.91
EPS:
-0.1487
Net Cash Flow:
$43.30M
1W Performance:
-3.48%
1M Performance:
-9.54%
6M Performance:
+29.24%
1Y Performance:
-17.06%
1-Day Range:
$38.46
$39.88
1-Week Range:
$37.58
$41.50
52-Week Range:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
38.50 | 5.97B | 3.44B | -8.30M | 43.30M | -0.1487 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BRKR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Artisan Partners Limited Partnership Invests $13.69 Million in Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
BRKR PE Ratio & Valuation, Is BRKR Overvalued - Intellectia AI
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker (NASDAQ: BRKR) outlines 2025 business segments, risks and $2.57B backlog - Stock Titan
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics With the Launch of CellScape XR - 富途牛牛
Is Bruker (BRKR) Now Offering Value After A Prolonged Share Price Slump? - Yahoo Finance
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
New Bruker tool targets 3,000-patient tumor study in spatial proteomics - Stock Titan
Reasons Why Bruker Corporation (BRKR) Appears So Attractive - Finviz
Inside Bruker and Noetik’s push toward 1B mapped human cells - Stock Titan
Bruker unveils spatial biology platforms at AGBT conference - Investing.com
Bruker unveils spatial biology platforms at AGBT conference By Investing.com - Investing.com Canada
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum – Company Announcement - Financial Times
Bruker announces board changes and declares quarterly dividend By Investing.com - Investing.com South Africa
Bruker announces board changes and declares quarterly dividend - Investing.com
Envestnet Asset Management Inc. Sells 43,490 Shares of Bruker Corporation $BRKR - MarketBeat
3D Protein Structure Analysis Market Report 2026 Featuring - GlobeNewswire
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players - Yahoo Finance UK
The Top 5 Analyst Questions From Bruker's Q4 Earnings Call - Finviz
Nasdaq Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Thursday - Intellectia AI
The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call - Yahoo Finance
Bruker (BRKR) executive exercises options and sells 2,000 shares - Stock Titan
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock - Yahoo Finance
Bruker Corp (BRKR) Shares Up 3.12% on Feb 17 - GuruFocus
Institutional Orbis investors report 9.8% Bruker (NASDAQ: BRKR) ownership stake - Stock Titan
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down - Nasdaq
US$48.43: That's What Analysts Think Bruker Corporation (NASDAQ:BRKR) Is Worth After Its Latest Results - 富途牛牛
Analysts Have Been Trimming Their Bruker Corporation (NASDAQ:BRKR) Price Target After Its Latest Report - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Analysts Conflicted on These Healthcare Names: Crispr Therapeutics AG (CRSP) and Bruker (BRKR) - The Globe and Mail
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $35 to $49 - 富途牛牛
Can Bruker Corporation expand into new marketsPortfolio Gains Summary & Stepwise Trade Execution Plans - mfd.ru
A Look At Bruker (BRKR) Valuation After Mixed Earnings And Soft 2026 Growth Outlook - Yahoo Finance
Bruker’s 2025 Earnings Call Maps a Cautious Recovery - TipRanks
Forecasting The Future: 15 Analyst Projections For Bruker - Benzinga
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
TD Cowen Issues Pessimistic Forecast for Bruker (NASDAQ:BRKR) Stock Price - MarketBeat
These Analysts Cut Their Forecasts On Bruker Following Q4 Results - Benzinga
Bruker (BRKR) Target Price Adjustment: Barclays Lowers Price Tar - GuruFocus
Bruker (BRKR) Is Down 8.6% After Mixed 2025 Results and Cautious 2026 Guidance Has The Bull Case Changed? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $40 to $53 - 富途牛牛
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% By Investing.com - Investing.com South Africa
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet News
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... - Yahoo Finance
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):